Relationship between 2-deoxy-2-[¹⁸F]-fluoro-d-glucose uptake and clinicopathological factors in patients with diffuse large B-cell lymphoma

References

• Smedby KE , Akerman M , Hildebrand H , et al. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut 2005; 54:54–59.
   PubMed Web of Science ®Google Scholar
• Juweid M , Stroobants S , Hoekstra OS , et al. Imaging Subcommittee of International Harmonization Project in Lymphoma. Use of positron emission tomography for response assessment of lymphoma: consensus of the imaging subcommittee of international harmonization project in lymphoma. J Clin Oncol 2007;25:571–578.
   PubMed Web of Science ®Google Scholar
• Cheson BD , Pfistner B , Juweid M , et al. International Harmonization Project on Lymphoma. Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25:579–586.
   PubMed Web of Science ®Google Scholar
• Smith TA . The rate-limiting step for tumor [18F] fluoro-2-deoxy-D-glucose (FDG) incorporation. Nucl Med Biol 2001;28:1–4.
   PubMed Web of Science ®Google Scholar
• Kitagawa Y , Sano K , Nishizawa S , et al. FDG-PET for prediction of tumour aggressiveness and response to intraarterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med Imaging 2003;30:63–71.
   PubMed Web of Science ®Google Scholar
• A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993;329:987–994.
   PubMed Web of Science ®Google Scholar
• Alizadeh AA , Eisen MB , Davis RE , et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503–511.
   PubMed Web of Science ®Google Scholar
• Nyman H , Adde M , Karjalainen-Lindsberg ML , et al. Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy. Blood 2007;109:4930–4935.
   PubMed Web of Science ®Google Scholar
• Niitsu N , Iijima K , Chizuka A . A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma. Eur J Haematol 2001;66:24–30.
   PubMed Web of Science ®Google Scholar
• Herishanu Y , Perry C , Braunstein R , et al. Early mid treatment C-reactive protein level is a prognostic factor in aggressive non-Hodgkins lymphoma. Eur J Haematol 2007;79:150–154.
   PubMed Web of Science ®Google Scholar
• Schöder H , Noy A , Gönen M , et al. Intensity of 18fluorodeoxygluocose uptake positron emission tomography distinguishes between indolent and aggressive non-Hodgkins lymphoma. J Clin Oncol 2005;23:4643–4651.
   PubMed Web of Science ®Google Scholar
• Hans CP , Weisenburger DD , Greiner TC , et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103: 275–282.
   PubMed Web of Science ®Google Scholar
• Nguyen XC , So Y , Chung JH , et al. High correlations between primary tumors and loco-regional metastatic lymph nodes in non- small cell lung cancer with respect to glucose transporter type 1-mediated 2-deoxy-2F18-fluoro-D-glucose uptake. Eur J Cancer 2008;44:692–698.
   PubMed Web of Science ®Google Scholar
• Tateishi U , Yamaguchi U , Seki K , et al. Glut-1 expression and enhanced glucose metabolism are associated with tumor grade in bone and soft tissue sarcomas; a prospective evaluation by [18F] fluorodeoxyglucose positron emission tomography. Eur J Nucl Med Mol Imaging 2006;33:683–691.
   PubMed Web of Science ®Google Scholar
• Yen TC , See LC , Lai CH , et al. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression. J Nucl Med 2004;45:22–29.
   PubMed Web of Science ®Google Scholar
• de Geus-Oei LF , van Krieken JH , Aliredjo RP , et al. Biological correlates of FDG uptake in non-small cell lung cancer. Lung Cancer 2007;55:79–87.
   PubMed Web of Science ®Google Scholar
• Kaida H , Hiromatsu Y , Kurata S , et al. Relationship between clinicopathological factors and fluorine-18-fluorodeoxyglucose uptake in patients with papillary thyroid cancer. Nucl Med Commun 2011;32:690–698.
   PubMed Web of Science ®Google Scholar
• Tohma T , Okazumi S , Makino H , et al. Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer. Hepatogastroenterology 2005;52:486–490.
   PubMed Web of Science ®Google Scholar
• Lyshchik AL , Higashi T , Hara T , et al. Expression of glucose transporter-1, hexokinase-II, proliferating cell nuclear antigen and survival of patients with pancreatic cancer. Cancer Invest 2007;25: 154–162.
   PubMed Web of Science ®Google Scholar
• Koga H , Matsuo Y , Sasaki M , et al. Differential FDG accumulation associated with GLUT-1 expression in a patient with lymphoma. Ann Nucl Med 2003;17:327–331.
   PubMed Web of Science ®Google Scholar
• Khandani AH , Dunphy CH , Meteesatien P , et al. Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomography. Nucl Med Commun 2009;30:594–601.
   PubMed Web of Science ®Google Scholar
• Shim HK , Lee WW , Park SY , et al. Expressions of glucose transporter type 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas. Nucl Med Biol 2009;36:191–197.
   PubMed Web of Science ®Google Scholar
• Higashi T , Saga T , Nakamoto Y , et al. Relationship between retention index in dual-phase (18) F-FDG PET and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med 2002;43:173–180.
   PubMed Web of Science ®Google Scholar
• Kaira K , Endo M , Abe M , et al. Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors. J Clin Oncol 2010;28:3746–3753.
   PubMed Web of Science ®Google Scholar
• Kaira K , Okumura T , Ohde Y , et al. Correlation between 18F-FDG uptake on PET and molecular biology in metastatic pulmonary tumors. J Nucl Med 2011;52:705–711.
   PubMed Web of Science ®Google Scholar
• Chihara D , Oki Y , Onoda H , et al. High maximum standard uptake value (SUV max) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma. Int J Hematol 2011;93:502–508.
   PubMed Web of Science ®Google Scholar
• Wu X , Pertovaara H , Korkola P , et al. Glucose metabolism correlated with cellular proliferation in diffuse large B-cell lymphoma. Leuk Lymphoma 2012;53:400–405.
   PubMed Web of Science ®Google Scholar
• Byun BH , Na II , Cheon GJ , et al. Clinical significance of 18F- FDG uptake by primary sites in patients with diffuse large B cell lymphoma in the head and neck: a pilot study. Ann Nucl Med 2008;22:645–651.
   PubMed Web of Science ®Google Scholar
• Watanabe R , Tomita N , Takeuchi K , et al. SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma. Leuk Lymphoma 2010;51:279–283.
   PubMed Web of Science ®Google Scholar
• Rosenwald A , Wright G , Chan WC , et al. Lymphoma/Leukemia Molecular Profiling Project. The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma. N Engl J Med 2002;346:1937–1947.
   PubMed Web of Science ®Google Scholar
• Lenz G , Wright G , Dave SS , et al. Stromal gene signatures in large B cell lymphomas. N Engl J Med 2008;359:2313–2323.
   PubMed Web of Science ®Google Scholar
• Younes M , Brown RW , Stephenson M , et al. Over expression of GLUT-1, and GLUT-3 in stage I non-small cell lung carcinoma is associated with poor survival. Cancer 1997;80:1046–1051.
   PubMed Web of Science ®Google Scholar
• Ayala FR , Rocha RM , Carvalho KC , et al. GLUT-1 and GLUT-3 as potential markers for oral squmaous cell carcinoma. Molecules 2010;15:2374–2387.
   PubMed Web of Science ®Google Scholar
• Ahn KJ , Hwang HS , Park JH , et al. Evaluation of the role of hexokinase type II in cellular proliferation and apoptosis using human hepatocelluar carcinoma cell lines. J Nucl Med 2009;50: 1525–1532.
   PubMed Web of Science ®Google Scholar
• Pizzi S , Porzionato A , Pasquali C , et al. Glucose transporter-1 expression and prognostic significance in pancreatic carcinogenesis. Histol Histopathol 2009;24:175–185.
   PubMed Web of Science ®Google Scholar
• Lapela M , Leskinen S , Minn HR , et al. Increased glucose metabolism in untreated non-Hodgkin lymphoma; a study with positron emission tomography and fluorine-18-fluorodeoxyglucose. Blood 1995;86:3522–3527.
   PubMed Web of Science ®Google Scholar
• Schoder H , Noy A , Gonen M , et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between aggressive non-Hodgkin cell lymphoma. J Clin Oncol 2005;23:4643–4651.
   PubMed Web of Science ®Google Scholar